Los 10 mejores resultados encontrados para "limits prolongs for medical cells of hiv material" en Recursos. Para acceder a todos los resultados y disfrutar de otras funciones, regístrate de forma gratuita.
... 1 Triggers Apoptosis in Primary Osteoblasts and HOBIT Cells Through TNFalpha Activation — Journal ofMedical Virology
Osteonecrosis — National Institute of Arthritis and Musculoskeletal and Skin Disease
Vitamin D Deficiency in HIV Infection: Not Only a Bone Disorder — BioMed Research International
...
... 1 Triggers Apoptosis in Primary Osteoblasts and HOBIT Cells Through TNFalpha Activation — Journal ofMedical Virology
Osteonecrosis — National Institute of Arthritis and Musculoskeletal and Skin Disease
Vitamin D Deficiency in HIV Infection: Not Only a Bone Disorder — BioMed Research International
...
... Neuropharmacology
Potential Adverse Drug Events and Drug-Drug Interactions With Medical and Consumer Cannabidiol (CBD) Use — Journal of Clinical Medicine
The Effects of Cannabinoids on the Pharmacokinetics of Indinavir and Nelfinavir — AIDS
...
... Neuropharmacology
Potential Adverse Drug Events and Drug-Drug Interactions With Medical and Consumer Cannabidiol (CBD) Use — Journal of Clinical Medicine
The Effects of Cannabinoids on the Pharmacokinetics of Indinavir and Nelfinavir — AIDS
...
... Department of Veterans Affairs
Stigma and HIV — Centers for Disease Control and Prevention
Supporting Retention in HIV Care Through a Holistic, Patient-Centred Approach: A Qualitative Evaluation — BMC Psychology
HIV Treatment as Prevention — Centers for Disease Control and Prevention ...
... Department of Veterans Affairs
Stigma and HIV — Centers for Disease Control and Prevention
Supporting Retention in HIV Care Through a Holistic, Patient-Centred Approach: A Qualitative Evaluation — BMC Psychology
HIV Treatment as Prevention — Centers for Disease Control and Prevention ...
... ofHIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds — International Journal of Molecular Sciences
HIV Vaccines — HIV.gov
Trends in HIV-2 Diagnoses and Use of the HIV-1/HIV-2 Differentiation Test — United States, 2010-2017 — Morbidity and Mortality Weekly Report
Treatment ofHIV-2 Infection — Wolters Kluwer UpToDate ...
... ofHIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds — International Journal of Molecular Sciences
HIV Vaccines — HIV.gov
Trends in HIV-2 Diagnoses and Use of the HIV-1/HIV-2 Differentiation Test — United States, 2010-2017 — Morbidity and Mortality Weekly Report
Treatment ofHIV-2 Infection — Wolters Kluwer UpToDate ...
... Centers for Disease Control and Prevention
La OMS recomienda el lenacapavir inyectable para la prevención del VIH — Organización Mundial de la Salud
...
... Centers for Disease Control and Prevention
La OMS recomienda el lenacapavir inyectable para la prevención del VIH — Organización Mundial de la Salud
...
... Control and Prevention
Measurement of Human Immunodeficiency Virus P24 Antigen — Clinical Infectious Diseases
Estimating Per-Act HIV Transmission Risk: A Systematic Review — AIDS ...
... Control and Prevention
Measurement of Human Immunodeficiency Virus P24 Antigen — Clinical Infectious Diseases
Estimating Per-Act HIV Transmission Risk: A Systematic Review — AIDS ...
únete
